Digital Therapeutics Alliance Applauds the Reintroduction of Bipartisan Legislation to Enable Public Coverage of Prescription Digital Therapeutics Creating Medicare and Medicaid benefit categories for digital therapeutics (DTx) is a critical step toward expanded patient access and appropriate reimbursement. March 9, 2023 — Arlington, VA — As the leading international organization on digital therapeutic (DTx) thought … Continue reading DTA Applauds the Reintroduction of Bipartisan Legislation to Enable Public Coverage of Prescription Digital Therapeutics